Crestchem Intrinsic Value
Crestchem (CRSTCHM) median intrinsic value is ₹66.67 from 10 valuation models (range ₹27–₹109), vs current price ₹88.85 — -25.0% downside (Trading Above Calculated Value), margin of safety -33.3%. For current market price and key ratios, visit Crestchem share price today.
CRSTCHM Valuation Methods Summary — DCF, Graham Number & P/E
Crestchem intrinsic value across 10 models vs current price ₹88.85 — upside/downside and value range per method. Browse Crestchem financial data for revenue, profit, balance sheet and cash flow data.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹81.60 | ₹65.28 - ₹97.92 | -8.2% | EPS: ₹6.80, Sector P/E: 12x |
| Book Value Method | asset | ₹26.67 | ₹24.00 - ₹29.34 | -70.0% | Book Value/Share: ₹26.67, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹66.67 | ₹60.00 - ₹73.34 | -25.0% | Revenue/Share: ₹83.33, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹58.33 | ₹52.50 - ₹64.16 | -34.4% | EBITDA: ₹3.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹90.56 | ₹72.45 - ₹108.67 | +1.9% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹108.80 | ₹97.92 - ₹119.68 | +22.5% | EPS Growth: 20.0%, Fair P/E: 16.0x |
| Growth Adjusted P/E | growth | ₹58.48 | ₹52.63 - ₹64.33 | -34.2% | Revenue Growth: 15.0%, Adj P/E: 8.6x |
| ROE Based Valuation | profitability | ₹106.67 | ₹96.00 - ₹117.34 | +20.1% | ROE: 25.0%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹53.33 | ₹48.00 - ₹58.66 | -40.0% | EPS: ₹6.80, BVPS: ₹26.67 |
| Dividend Yield Method | dividend | ₹28.57 | ₹25.71 - ₹31.43 | -67.8% | DPS: ₹1.00, Target Yield: 3.5% |
CRSTCHM Intrinsic Value vs Market Price — All Valuation Models
Crestchem fair value range ₹27–₹109 vs current market price ₹88.85 across 10 valuation models. Compare with CRSTCHM stock valuation models to assess whether the stock is under or overvalued.
CRSTCHM Intrinsic Value Analysis — Undervalued or Overvalued?
Crestchem median intrinsic value ₹66.67, current price ₹88.85 — Trading Above Calculated Value by 25.0%, margin of safety -33.3%.
What is the intrinsic value of CRSTCHM?
Based on our comprehensive analysis using 10 different valuation methods, the estimated intrinsic value of Crestchem (CRSTCHM) is ₹66.67 (median value). With the current market price of ₹88.85, this represents a -25.0% variance from our estimated fair value.
The valuation range spans from ₹26.67 to ₹108.80, indicating ₹26.67 - ₹108.80.
Is CRSTCHM undervalued or overvalued?
Based on our multi-method analysis, Crestchem (CRSTCHM) appears to be trading above calculated value by approximately 25.0%.
CRSTCHM Financial Health — Key Ratios vs Industry Benchmarks
Crestchem financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Debt to Equity Ratio | 1.38 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Return on Equity | 25.0% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 9.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 2.27x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
CRSTCHM Cash Flow Quality — Operating & Free Cash Flow
Crestchem operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹2 Cr | ₹2 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹0 Cr | ₹-1 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹2 Cr | ₹2 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹1 Cr | ₹1 Cr | Positive Free Cash Flow | 7/10 |
| March 2021 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |